跳至主要内容
临床试验/NCT04311645
NCT04311645Unknown2 期

Role of Oral Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous in Chronic Kidney Disease

Assiut University0 个研究点目标入组 90 人开始时间: 2020年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
90
主要终点
Mean of blood urea, creatinine and phosphorous in patients with CKD before and after oral activated charcoal

研究概览

简要总结

The study aims to explore the ability of Oral activated charcoal to adsorb uremic toxins limiting the progression of chronic kidney disease and delaying the need for hemodialysis in patients with CKD stages III and IV.

To compare its effect with the effect of dry seeds as absorbents of uremic toxins

详细描述

In recent years, chronic kidney disease(CKD) has become a worldwide public health issue.

The main factors affecting the prognosis of patients with chronic kidney disease are its complications, including cardiovascular and cerebrovascular diseases, malnutrition, inflammation, atherosclerosis syndrome, and anemia.

The accumulation of uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, is implicated in the progression of renal failure and cardiovascular disease.

For many patients, chronic kidney disease (CKD) is a progressive condition marked by deteriorating renal function ultimately leading to end-stage renal disease (ESRD) and many patients refuse to start chronic hemodialysis.

Therapeutic approaches that decrease the level of uremic toxins are a rational method for inhibiting this progression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with CKD stages iii and iv
  • Patients with age more than 18 years old

排除标准

  • Patients on regular hemodialysis
  • Patients with age less than 18 years old

研究组 & 干预措施

1st group

Other

Oral activated charcoal in a dose of 30 gm/day

干预措施: Activated charcoal (Drug)

2nd group

Other

Dry seeds in a dose of 1 gm/ day

干预措施: Dry seeds (Dietary Supplement)

结局指标

主要结局

Mean of blood urea, creatinine and phosphorous in patients with CKD before and after oral activated charcoal

时间窗: baseline

to asses the mean of blood urea, creatinine and phosphorous in CKD patient before and after administration of activated charcoal

次要结局

  • comparison of dry seeds and activated charcoal in limitting progression of chronic kidney disease(baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Farrag Sayed Mohamed

Resident Doctor, internal medicine department, principal investigator

Assiut University

相似试验

Role of Activated Charcoal in Decreasing Blood Urea,... | 临床试验